An Ensemble Basedheart Disease Predictionusing Gradient Boosting Decision Tree
Main Article Content
Abstract
Heart disease is now one of the deadliest diseases among the world. This crisis is affecting the bulk of people across the globe. Considering the massive death rate and huge amount of people suffering from the disease, the importance of early diagnosis of heart disease has been proven. Known cause for forecasting such a disease exist, but they really do not seem to be adequate. It is critical to develop a standard medical device that can foresee early heart diagnosis and have a more precise diagnosis than existing technologies such as Logistic Regularization, Lasso, Elastic Net, and Lasso Community Regularization.Ensemble classifiers are used in a variety of machine learning models that can increase forecasting ability in healthcare. Four databases are assembled in this paper, and 14 clinical features are fed into Ensemble. Traditional methods like SVM, AdaBoost, Logistic Regularization, and the existing Ensemble Prediction Model are compared to the proposed Ensemble Prediction Model in this paper. Across each experiment, the accuracy rate of the four datasets was 99 percent, outperforming other machine learning techniques and related academic studies. The performance metrics clearly show that the developed ensemble learning approach is superior. The findings show that the suggested ensemble can accurately predict the risk of cardiovascular disease.
Downloads
Metrics
Article Details
Licensing
TURCOMAT publishes articles under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This licensing allows for any use of the work, provided the original author(s) and source are credited, thereby facilitating the free exchange and use of research for the advancement of knowledge.
Detailed Licensing Terms
Attribution (BY): Users must give appropriate credit, provide a link to the license, and indicate if changes were made. Users may do so in any reasonable manner, but not in any way that suggests the licensor endorses them or their use.
No Additional Restrictions: Users may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.